218 related articles for article (PubMed ID: 21822308)
1. Functional interactions between Choline kinase α, epidermal growth factor receptor and c-Src in breast cancer cell proliferation.
Miyake T; Parsons SJ
Oncogene; 2012 Mar; 31(11):1431-41. PubMed ID: 21822308
[TBL] [Abstract][Full Text] [Related]
2. Choline Kinase α Mediates Interactions Between the Epidermal Growth Factor Receptor and Mechanistic Target of Rapamycin Complex 2 in Hepatocellular Carcinoma Cells to Promote Drug Resistance and Xenograft Tumor Progression.
Lin XM; Hu L; Gu J; Wang RY; Li L; Tang J; Zhang BH; Yan XZ; Zhu YJ; Hu CL; Zhou WP; Li S; Liu JF; Gonzalez FJ; Wu MC; Wang HY; Chen L
Gastroenterology; 2017 Apr; 152(5):1187-1202. PubMed ID: 28065789
[TBL] [Abstract][Full Text] [Related]
3. Signal transducer and activator of transcription 5b, c-Src, and epidermal growth factor receptor signaling play integral roles in estrogen-stimulated proliferation of estrogen receptor-positive breast cancer cells.
Fox EM; Bernaciak TM; Wen J; Weaver AM; Shupnik MA; Silva CM
Mol Endocrinol; 2008 Aug; 22(8):1781-96. PubMed ID: 18550772
[TBL] [Abstract][Full Text] [Related]
4. Met and c-Src cooperate to compensate for loss of epidermal growth factor receptor kinase activity in breast cancer cells.
Mueller KL; Hunter LA; Ethier SP; Boerner JL
Cancer Res; 2008 May; 68(9):3314-22. PubMed ID: 18451158
[TBL] [Abstract][Full Text] [Related]
5. STAT5b, a Mediator of Synergism between c-Src and the Epidermal Growth Factor Receptor.
Kloth MT; Laughlin KK; Biscardi JS; Boerner JL; Parsons SJ; Silva CM
J Biol Chem; 2003 Jan; 278(3):1671-9. PubMed ID: 12429742
[TBL] [Abstract][Full Text] [Related]
6. A functional siRNA screen identifies genes modulating angiotensin II-mediated EGFR transactivation.
George AJ; Purdue BW; Gould CM; Thomas DW; Handoko Y; Qian H; Quaife-Ryan GA; Morgan KA; Simpson KJ; Thomas WG; Hannan RD
J Cell Sci; 2013 Dec; 126(Pt 23):5377-90. PubMed ID: 24046455
[TBL] [Abstract][Full Text] [Related]
7. c-Src trafficking and co-localization with the EGF receptor promotes EGF ligand-independent EGF receptor activation and signaling.
Donepudi M; Resh MD
Cell Signal; 2008 Jul; 20(7):1359-67. PubMed ID: 18448311
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of biological synergy between cellular Src and epidermal growth factor receptor.
Tice DA; Biscardi JS; Nickles AL; Parsons SJ
Proc Natl Acad Sci U S A; 1999 Feb; 96(4):1415-20. PubMed ID: 9990038
[TBL] [Abstract][Full Text] [Related]
9. Urokinase receptor primes cells to proliferate in response to epidermal growth factor.
Jo M; Thomas KS; Takimoto S; Gaultier A; Hsieh EH; Lester RD; Gonias SL
Oncogene; 2007 Apr; 26(18):2585-94. PubMed ID: 17043637
[TBL] [Abstract][Full Text] [Related]
10. EBP50 inhibits EGF-induced breast cancer cell proliferation by blocking EGFR phosphorylation.
Yao W; Feng D; Bian W; Yang L; Li Y; Yang Z; Xiong Y; Zheng J; Zhai R; He J
Amino Acids; 2012 Nov; 43(5):2027-35. PubMed ID: 22476347
[TBL] [Abstract][Full Text] [Related]
11. Insulin-like growth factor-I receptor signaling in tamoxifen-resistant breast cancer: a supporting role to the epidermal growth factor receptor.
Knowlden JM; Hutcheson IR; Barrow D; Gee JM; Nicholson RI
Endocrinology; 2005 Nov; 146(11):4609-18. PubMed ID: 16037379
[TBL] [Abstract][Full Text] [Related]
12. A switch role of Src in the biphasic EGF signaling of ER-negative breast cancer cells.
Zhang X; Meng J; Wang ZY
PLoS One; 2012; 7(8):e41613. PubMed ID: 22927910
[TBL] [Abstract][Full Text] [Related]
13. Osteopontin induces AP-1-mediated secretion of urokinase-type plasminogen activator through c-Src-dependent epidermal growth factor receptor transactivation in breast cancer cells.
Das R; Mahabeleshwar GH; Kundu GC
J Biol Chem; 2004 Mar; 279(12):11051-64. PubMed ID: 14704150
[TBL] [Abstract][Full Text] [Related]
14. In vitro phosphorylation of the epidermal growth factor receptor autophosphorylation domain by c-src: identification of phosphorylation sites and c-src SH2 domain binding sites.
Lombardo CR; Consler TG; Kassel DB
Biochemistry; 1995 Dec; 34(50):16456-66. PubMed ID: 8845374
[TBL] [Abstract][Full Text] [Related]
15. TAE226-induced apoptosis in breast cancer cells with overexpressed Src or EGFR.
Golubovskaya VM; Virnig C; Cance WG
Mol Carcinog; 2008 Mar; 47(3):222-34. PubMed ID: 17849451
[TBL] [Abstract][Full Text] [Related]
16. TGF-beta1-induced plasminogen activator inhibitor-1 expression in vascular smooth muscle cells requires pp60(c-src)/EGFR(Y845) and Rho/ROCK signaling.
Samarakoon R; Higgins SP; Higgins CE; Higgins PJ
J Mol Cell Cardiol; 2008 Mar; 44(3):527-38. PubMed ID: 18255094
[TBL] [Abstract][Full Text] [Related]
17. Src family kinases mediate epidermal growth factor receptor signaling from lipid rafts in breast cancer cells.
Irwin ME; Bohin N; Boerner JL
Cancer Biol Ther; 2011 Oct; 12(8):718-26. PubMed ID: 21775822
[TBL] [Abstract][Full Text] [Related]
18. Potentiation of epidermal growth factor receptor-mediated oncogenesis by c-Src: implications for the etiology of multiple human cancers.
Maa MC; Leu TH; McCarley DJ; Schatzman RC; Parsons SJ
Proc Natl Acad Sci U S A; 1995 Jul; 92(15):6981-5. PubMed ID: 7542783
[TBL] [Abstract][Full Text] [Related]
19. 15-Lipoxygenase-1-enhanced Src-Janus kinase 2-signal transducer and activator of transcription 3 stimulation and monocyte chemoattractant protein-1 expression require redox-sensitive activation of epidermal growth factor receptor in vascular wall remodeling.
Singh NK; Wang D; Kundumani-Sridharan V; Van Quyen D; Niu J; Rao GN
J Biol Chem; 2011 Jun; 286(25):22478-88. PubMed ID: 21536676
[TBL] [Abstract][Full Text] [Related]
20. Involvement of pp60c-src with two major signaling pathways in human breast cancer.
Luttrell DK; Lee A; Lansing TJ; Crosby RM; Jung KD; Willard D; Luther M; Rodriguez M; Berman J; Gilmer TM
Proc Natl Acad Sci U S A; 1994 Jan; 91(1):83-7. PubMed ID: 7506422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
